These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 37554096)
1. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H J Clin Endocrinol Metab; 2024 Jan; 109(2):e817-e836. PubMed ID: 37554096 [TBL] [Abstract][Full Text] [Related]
2. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses. Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655 [TBL] [Abstract][Full Text] [Related]
4. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179 [TBL] [Abstract][Full Text] [Related]
5. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline. Goldberg A; Graca S; Liu J; Rao V; Witchel SF; Pena A; Li R; Mousa A; Tay CT; Pattuwage L; Teede H; Yildiz BO; Ee C Obes Rev; 2024 May; 25(5):e13704. PubMed ID: 38355887 [TBL] [Abstract][Full Text] [Related]
6. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H Eur J Endocrinol; 2023 Jul; 189(1):S1-S16. PubMed ID: 37440702 [TBL] [Abstract][Full Text] [Related]
7. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562 [TBL] [Abstract][Full Text] [Related]
8. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review. Forslund M; Melin J; Alesi S; Piltonen T; Romualdi D; Tay CT; Witchel S; Pena A; Mousa A; Teede H Clin Endocrinol (Oxf); 2023 Jul; 99(1):79-91. PubMed ID: 36939017 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews. Tay CT; Joham AE; Hiam DS; Gadalla MA; Pundir J; Thangaratinam S; Teede HJ; Moran LJ Clin Endocrinol (Oxf); 2018 Nov; 89(5):535-553. PubMed ID: 29846959 [TBL] [Abstract][Full Text] [Related]
10. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial. Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358 [TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials. Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801 [TBL] [Abstract][Full Text] [Related]
13. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358 [TBL] [Abstract][Full Text] [Related]
14. Statins for women with polycystic ovary syndrome not actively trying to conceive. Raval AD; Hunter T; Stuckey B; Hart RJ Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784 [TBL] [Abstract][Full Text] [Related]
15. Combined hormonal contraceptives for heavy menstrual bleeding. Lethaby A; Wise MR; Weterings MA; Bofill Rodriguez M; Brown J Cochrane Database Syst Rev; 2019 Feb; 2(2):CD000154. PubMed ID: 30742315 [TBL] [Abstract][Full Text] [Related]
16. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Zhao H; Xing C; Zhang J; He B Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851 [TBL] [Abstract][Full Text] [Related]
18. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Wu J; Zhu Y; Jiang Y; Cao Y Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522 [TBL] [Abstract][Full Text] [Related]
19. Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Lepine S; Jo J; Metwally M; Cheong YC Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009526. PubMed ID: 29125183 [TBL] [Abstract][Full Text] [Related]
20. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome]. Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]